Sign in

CIK 0001053369

  • Non-accelerated filer
  • Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
Operating
EIN
223542636
Phone
+1 201-750-2646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
Open-market buys, last 90 days
$25,980
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$25,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dash Barry H +$26K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-03-20 NARINE JEENARINE Director Grant or award +231,633 $0.10 $22K 63,998,251
2012-03-20 DICK CHRIS President & COO Grant or award +289,541 $0.10 $28K 740,541
2012-03-20 Ward Carter Julian Chief Financial Officer, Sec. Grant or award +289,541 $0.10 $28K 715,733
2012-03-20 Dash Barry H Director Grant or award +231,633 $0.10 $22K 608,519
2012-03-20 TREPPEL JERRY Chairman & CEO Grant or award +347,448 $0.10 $34K 1,854,341
2012-03-20 WHITNELL JEFFREY A Director Grant or award +231,633 $0.10 $22K 572,587
2012-03-16 NARINE JEENARINE Director Sale −85,000 $0.10 $9K 63,766,618
2012-03-16 NIGALAYE ASHOK G Chief Scientific Officer Sale −85,000 $0.10 $9K 63,766,618
2012-03-16 POTTI RAM Director Sale −85,000 $0.10 $9K 63,358,669
2012-03-16 EPIC PHARMA LLC 10% owner Sale −85,000 $0.10 $9K 63,358,669
2012-03-16 EPIC INVESTMENTS, LLC 10% owner Sale −85,000 $0.10 $9K 63,358,669
2012-03-15 EPIC PHARMA LLC 10% owner Grant or award · Series E Convertible Preferred Stock +125 $1,000.00 $125K 1,750
2012-03-15 NIGALAYE ASHOK G Chief Scientific Officer Grant or award · Series E Convertible Preferred Stock +125 $1,000.00 $125K 1,750
2012-03-15 NARINE JEENARINE Director Grant or award · Series E Preferred Stock +125 $1,000.00 $125K 1,750
2012-03-15 EPIC PHARMA LLC 10% owner Grant or award · Series E Preferred Stock +125 $1,000.00 $125K 1,750
2012-03-15 POTTI RAM Director Grant or award · Series E Convertible Preferred Stock +125 $1,000.00 $125K 1,750
2012-03-15 NARINE JEENARINE Director Purchase · Series E Convertible Preferred Stock +125 $1,000.00 $125K 1,750
2012-03-15 NIGALAYE ASHOK G Chief Scientific Officer Purchase · Series E Convertible Preferred Stock +125 $1,000.00 $125K 1,750
2012-03-15 POTTI RAM Director Purchase · Series E Convertible Preferred Stock +125 $1,000.00 $125K 1,750
2012-03-15 EPIC PHARMA LLC 10% owner Purchase · Series E Convertible Preferred Stock +125 $1,000.00 $125K 1,750

Page 24 of 28 · 542 trades